Optimal timing of anti-PD-1 antibody combined with chemotherapy administration in patients with NSCLC
A 3-day-delay sequential combination might increase antitumor responses and clinical benefits compared with the simultaneous combination.
Authors
- Tung‐Tien Sun (ORCID: https://orcid.org/0000-0002-6841-1063)
- Qitai Zhao (ORCID: https://orcid.org/0000-0003-4023-2060)
- Horng‐Dar Wang (ORCID: https://orcid.org/0000-0001-9570-3611)
- Yachang Huo
- Shundong Cang (ORCID: https://orcid.org/0000-0002-0146-7724)
- Wei Lv (ORCID: https://orcid.org/0000-0002-0866-7868)
- Guohui Qin (ORCID: https://orcid.org/0000-0001-9800-2343)
- Nayoung Han (ORCID: https://orcid.org/0000-0003-4796-8564)
- Yujie Xu (ORCID: https://orcid.org/0000-0002-8941-2479)
- Lihua Liu (ORCID: https://orcid.org/0000-0002-1201-4624)
- Yi Zhang (ORCID: https://orcid.org/0000-0001-9861-4681)
- Hong Liu (ORCID: https://orcid.org/0000-0001-9976-2985)
- Dan Wang (ORCID: https://orcid.org/0009-0000-9631-7050)
- Li Liu (ORCID: https://orcid.org/0000-0003-2314-8756)
- Lijun Miao (ORCID: https://orcid.org/0000-0002-7778-6908)
- Zhixin Zhang (ORCID: https://orcid.org/0000-0001-6440-6171)
- Yaqing Liu (ORCID: https://orcid.org/0000-0002-2885-1670)
- Hongjie Chen (ORCID: https://orcid.org/0000-0002-6438-108X)
- Kaiyuan Guo (ORCID: https://orcid.org/0009-0001-0621-9543)
- Yuqing Duan
- Feifei Fan (ORCID: https://orcid.org/0000-0002-5653-7654)
- Qingyang Lei
- Songyun Ouyang (ORCID: https://orcid.org/0000-0003-1707-1537)
- Shuangning Yang
- Liping Wang (ORCID: https://orcid.org/0000-0001-9355-1167)
- Chenhui Zhao
Institutions
- Hebei Medical University (CN)
- Union Hospital (HK)
- Henan University (CN)
- Chinese Center For Disease Control and Prevention (CN)
- Chengdu University of Technology (CN)
- Zhengzhou University (CN)
- Fourth Hospital of Hebei Medical University (CN)
- Second Affiliated Hospital of Zhengzhou University (CN)
- Henan Provincial People's Hospital (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Journal for ImmunoTherapy of Cancer
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1136/jitc-2024-009627
- Citations
- 16
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 4.52
Funders
- National Natural Science Foundation of China